Quick Takeaways
- FMR LLC filed SCHEDULE 13G for CYCLERION THERAPEUTICS INC COMMON STOCK (CYCN).
- Disclosed ownership: 15%.
- Date of event: 30 Apr 2026.
FMR LLC - 30 Apr 2026 SCHEDULE 13G Report for CYCLERION THERAPEUTICS INC COMMON STOCK (CYCN)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- CYCN
- Shares outstanding
- 4,330,313 shares
- Disclosed Ownership
- 649,547 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13G
- Filing time
- 07 May 2026, 10:42:01 UTC
- Date of event
- 30 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 15% ownership in CYCLERION THERAPEUTICS INC COMMON STOCK (CYCN) on 30 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 May 2026, 10:42.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | 649,547 | 649,547 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 15% | 649,547 | 0 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson* |